Replies to post #525165 on NorthWest Biotherapeutics Inc (NWBO)

[FeMike]

Were you able to catch it? Any notes?

Thanks!

[Dr Bala]

Thanks for the highlight, Lykiri.

[flipper44]

Thanks! Makes me think more and more that the as yet undisclosed confirmed progression endpoint analysis will be extremely important.

Your post was the best post of the day.

[ATLnsider]

Thanks Lykiri

[Poor Man -]

Was it via conference call or were you in Oakland?

Interesting. Thanks for sharing.

[hoffmann6383]

good stuff. thanks lykiri!

[StonkMaster]

Sorry, I'm dense.

Is she talking about the combo trial?

[ae kusterer]

Lykiri : Is Dr.Liau changing the prior 13% alive at 5 years to a higher number? A.E.K.

Re: FeMike post# 525140

Wednesday, October 26, 2022 6:26:58 PM

Post#
525165
of 525193
Wednesday, October 26, 2022
4pm-5pm

Linda Liau, MD, PhD, MBA
W. Eugene Stern Professor & Chair
Chair & Executive Medical Director
UCLA Department of Neurosurgery
Director, UCLA Brain Tumor SPORE
David Geffen School of Medicine & UCLA Health

“The Promise of Immunotherapy for Treatment of Glioblastoma”

Long tail (5 years)
LL
"5 years... not just survival but 5 years without recurrence"

Great Lecture.

[hyperopia]

Thanks. If it was anyone else who posted that cryptic message, I wouldn’t have believed them. :)

[eagle8]

As always, thank you Lykiri.

GLTU

[biosectinvestor]

Thanks Lykiri! Given she is discussing 5 year survival, has to be the Phase 3 or another older trial arm as well, such as the adjuvant trial that continues. But I am assuming it is the Phase 3 given the necessary timeline to speak confidently of such an outcome for 5 year survivors.